
|Videos|January 30, 2023
Combination Ruxolitinib and Selinexor for the Treatment of Naïve Myelofibrosis
Author(s)Joshua Richter, MD, Srdan Verstovsek, MD, PhD
Srdan Verstovsek, MD, reviews data presented at ASH 2022 on combination ruxolitinib and selinexor for the frontline treatment of myelofibrosis.
Episodes in this series








































